Is Ukrainian Defense-Tech Investable? The Objections, Answered

Be precise about the gap, because the loose version invites a fair objection. The $35 billion figure is annual production capacity— built from ~$1 billion in 2022 — and most of it is bought by the Ukrainian state and, increasingly, allied governments (roughly $6 billion flowed in via the Danish model and partner procurement in 2025). It is not a private market cap. Set against it, disclosed private venture in 2025 was about $57 million (PitchBook).

So the thesis is not “a $35B market trades at $57M.” It is sharper than that: the customer is already spending tens of billions a year with companies that have taken almost no private equity. You can back a proven supplier to that demand at seed-stage prices — before the private market finds it. That is the mispricing, and it is defensible.

The five objections below are the ones that actually come up in a committee. Three have clean answers; two — repatriation and the end of the war — stay genuinely hard, and I will say so.

The mistake is one blanket number for “Ukraine risk” applied to the whole deal. Investable structures isolate what the war actually threatens and price only that.

• The value sits offshore. The holding company and the IP live outside Ukraine, so the asset you own is not physically on the front line.
• Production is distributed. Manufacturing is dispersed across many sites and, increasingly, duplicated with partners abroad — the sector was built decentralized precisely because it is under attack.
• Mobilization is a named risk. Founders and engineers can be called up. Investable companies plan for it — critical-personnel reservation, documented key-person cover — rather than leave it to chance.
• What remains is priced, not feared. A risk register discounts the specific, bounded exposures — single-site, supply, counterparty, FX — instead of a haircut that mistakes a headline for a model.

A foreign investor does not buy the Ukrainian wartime entity directly. They take equity in a cross-border holding that owns the operating company and its IP — the structure built to be legally held and exited by outside capital. Two defense-specific caveats matter, and they are exactly why the structuring is work, not a formality:

• Moving the IP offshore is itself export-controlled.Assigning military or dual-use IP to a foreign holding can trigger Ukraine's export-control regime and interagency approval — it has to be done on the right path, not assumed.
• Getting capital out needs a route. Wartime capital controls restrict dividend repatriation from Ukraine. The answer is to design cash flow around it — export revenue and IP licensing landing at the offshore holding — so returns are not trapped behind the border. This is a real constraint, handled by structure, not wished away.

The mechanics of each route in — direct equity, fund, strategic, non-dilutive — are laid out in the routes-in guide.

The perception is fair; the answer is not a promise but a paper trail that meets an institutional bar before the raise. Ukraine has also built the infrastructure that makes it checkable:

• Procurement is increasingly transparent — Prozorro and digital defense procurement leave an auditable record of who sells what to the state.
• Companies are pre-vetted in the ecosystem — Brave1 and the clusters screen and document companies well before they reach an investor.
• Beneficial ownership and sanctions are screened — the one regional risk that is non-negotiable is Russian-linked capital or supply in the structure; it is checked and cleared, or the deal does not happen.

On top of that sits the ordinary institutional list: clean, separated financials; IP assigned to the company; a documented combat record and contract base — a data room built to survive third-party review. Opacity is precisely what that diligence is there to separate out.

Be honest here, because overselling it is the fastest way to lose a serious investor. Realized liquidity is early, not deep.

• Public markets — precedent, not a deep market. In March 2026 Swarmerbecame the first Ukrainian defense-tech company to IPO on Nasdaq (ticker SWMR). It was a small raise — about $15 million — and the several-fold first-day pop reflects a thin float, not a liquid market. What it proves is narrower and still valuable: the public door now opens for a Ukrainian defense company.
• Strategic M&A — the credible exit today. Primes and platform companies buying combat-proven capability and teams is the quieter, more frequent path, and the one most deals are actually built toward.
• A priced benchmark, not an exit.UFORCE's $1 billion round (raising $50 million while already profitable, on 450% revenue growth) is a valuation mark the sector can be measured against — but a primary raise is a markup, not liquidity. Do not count it as one.

In most markets “pre-revenue” means unvalidated. Here it is the opposite: a product that has worked against a peer adversary carries proof a lab or a range cannot manufacture — which is why independent testing in Ukraine has become a diligence input in its own right.

But combat-proven is not automatically scalable. The system that wins on the Ukrainian front may not meet allied procurement specs, standards or supply-chain rules. The return lives on the bridge between the two: NATO codification and export-readiness lift the ceiling from a single domestic buyer to allied markets, and a US-eligible structure plus codification opens non-dilutive revenue — SBIR, STTR and OTA pay for the technology without taking equity. Early here does not mean unproven; it means priced before that bridge is built.

This is the question a serious investor asks first and a sell-side deck avoids. It deserves a straight answer, because it decides which companies are actually investable.

The bear case is real. A ceasefire removes the wartime demand surge. Single-product FPV shops selling only to the domestic front face a demand cliff and a valuation reset; some will not survive peace. Pretending otherwise is how you lose money.

The bull case is the pivot, and it is already underway.Exports opened in 2026; Europe is rearming for a decade regardless of Ukraine's front line; combat-proven, codified products are exactly what allied militaries now want to buy; and reconstruction turns much of the dual-use base toward civilian demand. The companies built for a single wartime customer are exposed; the ones built to export a proven product to allied markets are the ones peace rewards. If your thesis needs the war to continue, you have picked the wrong company — which is precisely what the diligence is for.

The sector is investable; not every company in it is. The line is rarely the technology — it is whether these are in place, or can be put in place before the money moves:

• A cross-border holding a foreign investor can legally own and exit.
• IP assigned to the company and cleared for offshore structuring — one of the largest single swings in value.
• A repatriation route — cash flow designed to reach the holding, not trapped by capital controls.
• An export path mapped — licensing and codification, so revenue is not capped at one customer, and the product survives peace.
• Key-person and mobilization cover, diversified buyers, and clean, separated financials in a verified data room.
• A documented combat record — evidence, not anecdote.

A company with these is underwritable today. A company missing them is not un-investable — it is un-prepared, and the distance between the two is work, not fate. Building exactly that — the offshore structure, the export and codification path, the risk register, the data room, independent testing — before a company reaches your committee is the work Wiseboard does on the ground in Ukraine.